NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...

It's been an up-and-down year for NxStage Medical (NASDAQ: NXTM) shareholders. The medical technology company's stock dropped over 35% by mid-February only to rebound strongly over the past three ...

Here's the good news the dialysis specialist needed. Over the past couple of weeks, two SEC filings from NxStage have provided more color on where the dialysis specialist is headed. With the ...

LAWRENCE, Mass., Aug. 24, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the NxStage® System One™ ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio With Medicare offering financial ...

NxStage Medical (NASDAQ: NXTM) has been in limbo since mid-2017, when it received an offer from Fresenius Medical Care (NYSE: FMS) to buy the company. Since then, shares of NxStage have stayed ...

Medical device firm NxStage Medical Inc. says that it has raised $43 million through private placement of its common stock and warrants. Officials at Lawrence-based NxStage (Nasdaq: NXTM) said the ...

NxStage® Medical, Inc., a manufacturer of dialysis products, celebrated the grand opening of its new headquarters in Lawrence, MA, in a special ceremony this week with Gov. Deval Patrick and other ...

Find out why concerns about the dialysis specialist's merger are getting worse. NxStage hasn't made a regular press release with quarterly financial results since it received its buyout bid from ...